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ABSTRACT: Multiplexed quantitation via isobaric chemical
tags (e.g., tandem mass tags (TMT) and isobaric tags for relative
and absolute quantitation (iTRAQ)) has the potential to
revolutionize quantitative proteomics. However, until recently
the utility of these tags was questionable due to reporter ion
ratio distortion resulting from fragmentation of coisolated
interfering species. These interfering signals can be negated
through additional gas-phase manipulations (e.g., MS/MS/MS
(MS3) and proton-transfer reactions (PTR)). These methods,
however, have a signiﬁcant sensitivity penalty. Using isolation
waveforms with multiple frequency notches (i.e., synchronous
precursor selection, SPS), we coisolated and cofragmented
multiple MS2 fragment ions, thereby increasing the number of
reporter ions in the MS3 spectrum 10-fold over the standard MS3 method (i.e., MultiNotch MS3). By increasing the reporter ion
signals, this method improves the dynamic range of reporter ion quantitation, reduces reporter ion signal variance, and ultimately
produces more high-quality quantitative measurements. To demonstrate utility, we analyzed biological triplicates of eight colon
cancer cell lines using the MultiNotch MS3 method. Across all the replicates we quantiﬁed 8 378 proteins in union and 6 168
proteins in common. Taking into account that each of these quantiﬁed proteins contains eight distinct cell-line measurements,
this data set encompasses 174 704 quantitative ratios each measured in triplicate across the biological replicates. Herein, we
demonstrate that the MultiNotch MS3 method uniquely combines multiplexing capacity with quantitative sensitivity and
accuracy, drastically increasing the informational value obtainable from proteomic experiments.
Mass spectrometry (MS) based quantitative proteomicshas traditionally been limited to binary and ternary
comparisons (e.g., SILAC based quantitation).1−4 As such,
proteomics has trailed behind the technologies employed in
transcriptome analysis. Multiplexed quantitation via isobaric
chemical tags (e.g., tandem mass tags (TMT) and isobaric tags
for relative and absolute quantitation (iTRAQ)) provide an
avenue for greater parallelization of quantitative mass
spectrometry.5−7
Identical peptides, derived from diﬀerent samples, and
labeled with diﬀerent versions of the isobaric tags, are
indistinguishable in their intact form. However, upon isolation
and fragmentation in the mass spectrometer, each peptide
variant produces a unique reporter ion. Multiplexing
quantitative analyses through multichannel isobaric tagging
shows great promise for its ability to (1) improve throughput,
(2) increase the breadth of coverage by avoiding missing values,
and (3) deepen analysis by simplifying complex chromatograms
that are typically populated by multiple forms of the same
peptide.8
In theory, the abundance of the isobaric tag reporter ions
should be directly proportional to the relative amount of each
precursor in each sample. In practice, however, coisolation and
cofragmentation of interfering ions results in distorted TMT
ratios. Reporter ions originating from the isobaric tags of the
target population are indistinguishable from reporter ions
originating from any interfering ions. Therefore, any coisolated
interfering precursor ions will contribute to the ﬁnal reporter
ion population in an unpredictable manner that obfuscates the
true reporter ion intensities.
This interference phenomenon was detailed recently in a
series of publications.9−15 Using a two-proteome model, we
showed that nearly all the measurements obtained with
standard tandem MS (i.e., MS2) were distorted by interfering
ions. We also demonstrated that an MS3 spectrum based on
one of the TMT labeled MS2 fragment ions can mitigate the
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negative impact of these interfering signals.14 Alternative
methods that utilize ion−ion chemistry in place of energetic
fragmentation have been demonstrated.15 While the additional
round of gas-phase selectivity provided by these MS3 methods
dramatically reduces the contribution of any interfering signals,
it also reduces overall sensitivity. By dividing the initial
precursor signal among all the possible product ions and
selecting only a single product ion for subsequent interrogation,
only a small percentage of MS1 precursor ions are converted
into the MS3 reporter ions.
Herein, we describe a solution to the sensitivity limitations of
the MS3 method, in which we use isolation waveforms with
multiple frequency notches for synchronous precursor selection
(SPS) of multiple MS2 fragment ions. We fragment the
aggregate MS3 precursor population (i.e., MultiNotch MS3) to
produce a reporter ion population that is far more intense than
the population we would have produced had we only
fragmented a single MS2 ion. At the same time, we maintain
the selectivity of the standard MS3 method by carefully deﬁning
the isolation notches of the SPS isolation waveform to ensure
high isolation speciﬁcity of the target MS2 fragment ions. In
summary, we introduce a new quantitative proteomic method,
which provides a unique combination of multiplexing capacity,
high sensitivity, and quantitative accuracy.
■ METHODS
Two-Proteome Interference Model. The two-proteome
interference model was prepared as previously.14,16 HeLa S3
cells were grown in suspension to 1 × 106 cells/mL. Yeast cells
were grown to an OD of 1.0. Cells were lysed in 6 M
guanidiumthiocyanate, 50 mM Hepes (pH 8.5, HCl). Protein
content was measured using a BCA assay (Thermo Scientiﬁc),
disulﬁde bonds were reduced with dithiothreitol (DTT), and
cysteine residues were alkylated with iodoacetamide as
previously described.17 Protein lysates were cleaned with
methanol−chloroform precipitation.18 The samples were
redissolved in 6 M guanidiumthiocyanate, 50 mM Hepes pH
8.5, and diluted to 1.5 M guanidium thiocyanate, 50 mM Hepes
(pH 8.5). Both lysates were digested overnight with Lys-C
(Wako) in a 1/50 enzyme/protein w/w ratio. Following
digestion, the sample was acidiﬁed with TFA to a pH < 2 and
subjected to C18 solid-phase extraction (SPE, Sep-Pak, Waters).
The TMT reagents were dissolved in 40 μL of acetonitrile,
and 10 μL of the solution was added to 100 μg of peptides
dissolved in 100 μL of 50 mM HEPES (pH 8.5). After
incubating for 1 h at room temperature (22 °C), the reaction
was quenched by adding 8 μL of 5% w/v hydroxylamine.
Following labeling, the sample was combined in desired ratios.
Yeast aliquots were mixed at 10:4:1:1:4:10, and HeLa was
mixed at 1:1:1:0:0:0 (Figure 1A). Those two samples were then
mixed at a 1/1 w/w ratio and subjected to C18 solid-phase
extraction.
Colorectal Cancer Cell Culture, Sample Preparation,
and TMT Labeling. Colo205, LoVo, DLD-1, SW48, HT-29,
HCT-15, HT55, and HCT-116 cells were cultured in 15 cm
plates containing RPMI, 10% FBS, penicillin, and streptomycin.
Each cell line was grown in 10% CO2 to ∼90% conﬂuence.
Cells were starved for 4 h in RPMI, washed 3 times with 15 mL
of cold PBS, harvested into an Eppendorf tube, and snap frozen
in liquid nitrogen. Following harvesting, the remaining sample
Figure 1. (A) Yeast was digested with LysC and labeled with TMT (10:4:1:1:4:10). That sample was combined with a TMT labeled HeLa sample
(1:1:1:0:0:0). (B) A TMT-labeled, yeast peptide (NAAWLVFANK) was interrogated in back-to-back scans using (left spectrum) MS2, where the
MS1 precursor was fragmented using HCD. (Middle) MS3, where the MS1 precursor was fragmented with CID, and a single MS2 product ion was
isolated and fragmented using HCD. And, (right) MultiNotch MS3, where multiple MS2 product ions were simultaneously isolated and fragmented.
(C) The precursor populations of the standard and MultiNotch MS3 scans used to generate the reporters above (middle and bottom spectra,
respectively). For reference, we also include the ITMS2 spectrum prior to MS3 precursor isolation (top).
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steps in the sample preparation process closely matched the
steps of the two-proteome sample (Supporting Information).
Basic-pH Fractionation and Low-pH Reverse Phase LC
Analysis. Human colorectal peptides were subjected to basic-
pH reverse-phase HPLC fractionation. Mixed and labeled
peptides were solubilized in buﬀer A (5% ACN, 10 mM
ammonium bicarbonate, pH 8.0) and separated on an Agilent
300 Extend C18 column (5 μm particles, 4.6 mm i.d., and 20
cm in length). Using an Agilent 1100 binary pump equipped
with a degasser and a photodiode array (PDA) detector, a 50
min linear gradient from 18% to 45% acetonitrile in 10 mM
ammonium bicarbonate pH 8 (ﬂow rate of 0.8 mL/min)
separated the peptide mixture into a total of 96 fractions. The
96 fractions were consolidated into 24 samples, acidiﬁed with
10% formic acid, and vacuum-dried. Each sample was
redissolved with 5% formic acid/5% ACN, desalted via
StageTip, dried via vacuum centrifugation, and reconstituted
for LC−MS/MS analysis.
All LC−MS experiments were performed on a Velos-
Orbitrap Elite mass spectrometer (Thermo Fischer Scientiﬁc)
coupled to a Proxeon nLC-1000 (Thermo Fisher Scientiﬁc)
ultra high-pressure liquid chromatography (UPLC) pump.
Peptides were separated on a 75 μm inner diameter
microcapillary column. The tip for the column was pulled in-
house and the column was packed with approximately 0.5 cm of
Magic C4 resin (5 μm, 100 Å, Michrom Bioresources) followed
by 25 cm of Sepax Technologies GP-C18 resin (1.8 μm, 120
Å). Separation was achieved by applying a 3−22% ACN
gradient in 0.125% formic acid over 165 min at ∼300 nL/min.
Electrospray ionization was enabled by applying a voltage of 2.0
kV through an IDEX high-pressure ﬁtting at the inlet of the
microcapillary column. In the case of the two-proteome
mixture, the linear gradient was shortened to 70 min.
Implementation of the MultiNotch MS3 Method. The
implementation of the isolation waveforms for synchronous
precursor selection was the greatest hurdle toward implement-
ing the MultiNotch MS3 method. All instrument modiﬁcations
needed to enable this method were performed in-house and
entailed changes to the instrument control code. The
fundamental technologies of this method are ion traps and
notched isolation waveforms. The idea of concurrently isolating
multiple discrete ion populations with isolation waveforms that
have multiple frequency notches was developed in the mid-
1980s, when much of the original work was done in the
laboratories of Marshall19,20 and McLaﬀerty.21 Since then
Cooks, McLuckey, and others have contributed to the ﬁeld.22,23
Yet, this is the ﬁrst time this technology has ever been used in
an online, large-scale proteomics experiment with multiplexed
quantitation. Brieﬂy, these waveforms isolate the ions of
interest by ejecting unwanted ions through energetic excitation.
The frequencies comprising the isolation waveform excite the
trapped ions through on-resonance excitation. However, where
a notch exists in the list of frequencies, the ions remain stably
trapped (Figure S1 in the Supporting Information).
All of the initial development work for this method was
focused on deﬁning equations that could accurately describe
the size and location for any possible notch in the SPS
waveform. To this end, we injected mixtures of ions with
known m/z values into the instrument, and we isolated those
ions using a series of SPS isolation waveforms. During these
experiments, we varied the notch width and location, and the
isolation eﬃciency was recorded as a function of those
parameters. Figure 2A shows the data generated by performing
this analysis on an ion with 989 m/z. As the q-value of the ion
varies, so does the optimal position and width of the isolation
notch. This type of analysis was repeated for many ions, and the
resulting aggregate data sets were ﬁtted using linear regression
(Figure S2 in the Supporting Information).
With these equations in hand, we could deﬁne isolation
waveforms for any ensemble of ions. Typically we captured 10
MS2 fragment ions in our MS3 precursor population.
Surprisingly, by simply isolating 10 MS2 fragment ions, we
are able to retain ∼40% of the MS2 total ion current in the
MS3 precursor population (Figure 2B). Coupling in the losses
from CID, we typically retained ∼25% of our initial MS1
population in the MS3 precursor population. This was a vast
improvement over the traditional MS3 approach, where only
∼5% of the initial precursor population was retained.
In addition to the waveform declaration algorithms, we
employed functions that intelligently scaled the precursor
injection time based upon the expected TMT signal
(Supporting Information). Coupled together, these features
for selecting precursors, declaring the MultiNotch MS3
isolation waveform, and intelligently scaling ion injection
times resulted in a 10-fold increase in TMT reporter ion
intensities with the MultiNotch MS3 approach, relative to the
standard MS3 scan type (Figure 3A).
Mass Spectrometry. The mass spectrometer was operated
in data-dependent mode for both the MS2 and MS3 methods.
For both methods we collected a survey scan of 300−1 500
m/z in the Orbitrap at a resolution of 60 000 (FTMS1) and an
AGC target of 1 × 106. We selected the 10 most intense ions
for MS analysis. Precursor ions were ﬁltered according to
charge state (required >1z), dynamic exclusion (40 s with a
±10 ppm window), and monoisotopic precursor selection.
During the MS2 analyses, precursors were fragmented by
high-energy collision induced dissociation (HCD) followed by
Figure 2. (A) While infusing an ion with an m/z ratio of 989, we
varied the isolation notch width and location. We recorded the
isolation eﬃciency as a function of those parameters. This analysis was
repeated for the series of ions, and the resulting data set was ﬁtted
using linear regression. (B) During a 90 min MultiNotch LC−MS2/
MS3 analysis of the yeast/human two-proteome sample, we isolated
the MS3 precursor population without any subsequent fragmentation.
We then calculated the fraction of MS2 ions retained in the MS3
precursor population.
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Orbitrap analysis (FTMS2). FTMS2 precursors were isolated
using a width of 2.0 m/z and fragmented with a normalized
collision energy of 40. Precursors were accumulated to an AGC
target of 5 × 104 or a maximum injection time of 250 ms.
During the MS3 analyses, the MS1 precursors were ﬁrst
interrogated by ITMS2 using CID. Precursors were isolated
using a 1.2 m/z isolation window. They were accumulated to an
AGC target of 5 000 or a maximum injection time of 125 ms.
This ITMS2 spectrum was used to determine the conditions of
the MS3 analysis (e.g., which fragments to interrogate). For the
MS3 scan, the MS1 precursor was isolated using a 2.5 m/z wide
window and fragmented with CID. Following fragmentation,
the MS3 precursor population was isolated using the SPS
waveform and then fragmented by HCD. The HCD
normalized collision energy was set to 50. The m/z value
used in the NCE calculation was the weighted average of all the
MS3 precursor ions. During the MS3 analysis we used an
online isolation speciﬁcity ﬁlter (Supporting Information).
MS2 Spectra Assignment, Data Processing, and
Protein Assignment. Following data acquisition, Thermo
RAW ﬁles were processed using a series of software tools that
were developed in-house. First the RAW ﬁles were converted to
mzXML using a custom version of ReAdW.exe (http://sashimi.
svn.sourceforge.net/viewvc/sashimi/) that had been modiﬁed
to export ion accumulation times and FT peak noise. During
this initial processing we also corrected any erroneous
assignments of monoisotopic m/z. Using Sequest,24 MS2
spectra were searched against the human UniProt database
(downloaded on 08/02/2011), supplemented with the
sequences of common contaminating proteins such as trypsin.
This forward database was followed by a decoy component,
which included all target protein sequences in reversed order.
Searches were performed using a 50 ppm precursor ion
tolerance.25 When searching Orbitrap MS2 data, we used 0.02
Th fragment ion tolerance. The fragment ion tolerance was set
to 1.0 Th when searching ITMS2 data. Only peptide sequences
with both termini consistent with the protease speciﬁcity of
LysC were considered in the database search, and up to two
missed cleavages were accepted. TMT tags on lysine residues
and peptide N-termini (+ 229.162932 Da) and carbamidome-
thylation of cysteine residues (+ 57.02146 Da) were set as static
modiﬁcations, while oxidation of methionine residues (+
15.99492 Da) was treated as a variable modiﬁcation. An MS2
spectral assignment false discovery rate of less than 1% was
achieved by applying the target-decoy strategy.26 Filtering was
performed using linear discriminant analysis as described
previously27 to create one composite score from the following
peptide ion and MS2 spectra properties: Sequest parameters
XCorr and unique ΔCn, peptide length and charge state, and
precursor ion mass accuracy. The resulting discriminant scores
were used to sort peptides prior to ﬁltering to a 1% FDR, and
the probability that each peptide-spectral-match was correct
was calculated using the posterior error histogram.
Following spectral assignment, peptides were assembled into
proteins and proteins were further ﬁltered based on the
combined probabilities of their constituent peptides to a ﬁnal
FDR of 1%. In cases of redundancy, shared peptides were
assigned to the protein sequence with the most matching
peptides, thus adhering to principles of parsimony.28
Quantitative Data Analysis and Data Presentation.
When analyzing TMT reporter ion signals, we used the ratio
between the reporter ion intensity and the peak noise. This
ratio has been shown to scale quite well with the number of
ions in the Orbitrap peak, i.e., ∼5 charges are equal to a S/N
ratio of 1.29 Hence, this ratio is more meaningful when making
qualitative judgments about the ion statistics of a given reporter
signal than the injection time scaled intensity. The isotopic
impurities of the TMT reagent were corrected using the values
speciﬁed by the manufacturer.30
When processing the colorectal cancer data, we ﬁltered our
data to only include quantitative spectra that possessed a
summed TMT reporter S/N of 100. On the basis of previous
work and simulation, this was determined to be the minimum
number of reporter ions necessary to ensure that ion statistics
would not be a source of signiﬁcant reporter variance (Figure
S6 in the Supporting Information).31
Using our protein-level peptide grouping as a guide, we
summed the TMT signals from the peptide level quantitative
spectra to produce our protein level quantitative data. These
quantitative signals were summed across all quantiﬁed proteins,
and then these sums were normalized across all TMT reporter
channels, hence, correcting for minor mixing errors and
reﬂecting equal total protein content per cell line. These
normalized intensities were then scaled across each protein to a
net total of 100.
To look for proteins that were signiﬁcantly altered in at least
one colorectal cancer cell line, we used a one-way analysis of
variance (ANOVA) with Welch’s correction to control for
unequal variances between TMT channels.32 An false discovery
rate (FDR) of 1% was controlled using the Benjamini−
Hochberg method. The ReactomeFI analysis was performed
using the Cytoscape plug-in provided by the developers.33
Principal components analysis was performed using R (R Core
Figure 3. TMT-labeled, two-proteome mixture (yeast/human) was
analyzed by LC−MS2, standard MS3, and MultiNotch MS3. (A) We
distributed the quantitative spectra by the number of TMT reporter
ions. (B) We also distributed the quantitative spectra using three select
TMT ratios (channels 126:128, 127:128, and 128:129, i.e., 10:1, 4:1,
and 1:1). The expected ratios are denoted using the dashed lines.
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Team, Vienna, Austria, http://www.R-project.org). PC1
loadings were extracted and sorted by absolute value to choose
the top contributors. All proteins from the Vogelstein et al.
gene set that were quantiﬁed in the MultiNotch MS3 data set
were extracted and mean expression values across all replicates
were used to calculate a Euclidean distance to SMAD4 and
IDH2. Proteins were then sorted by this distance to produce
the nearest expression proﬁles.
■ RESULTS
Coisolating and Cofragmenting Multiple MS2 Frag-
ment Ions. Using isolation waveforms with multiple frequency
notches, we coisolated and cofragmented multiple MS2
fragment ions during our MS3 analyses (MultiNotch MS3).
We implemented this method with the aim of increasing the
number of TMT reporter ions in the resulting quantitative MS3
spectrum. However, with the MultiNotch MS3 method we
employ multiple isolation notches, and some of those notches
tend to be larger than the isolation notches of the standard
MS3 method (see Methods); hence, we lose some selectivity
with the MultiNotch method compared to the standard. With
these concerns in mind, we benchmarked the MultiNotch MS3
method using a two-proteome model to measure ratio
distortion and sensitivity.14
We digested a yeast lysate with LysC, labeled separate
aliquots using TMT, and then mixed those aliquots at
10:4:1:1:4:10 (Figure 1A). We also digested a human lysate
using LysC, labeled three aliquots, and mixed those aliquots at
ratios of 1:1:1. Finally, the labeled human and yeast peptide
mixtures were combined at a 1:1 ratio.
For all subsequent analyses, we treated the yeast peptides as
the target population, and the human peptides as the interfering
ions. In the absence of any interfering human signals, yeast
peptides should produce a reporter ion distribution that
corresponds to the mixing ratios (i.e., 10:4:1:1:4:10). However,
with the MS2 method we generally observed a distortion of
these intensities. This is exempliﬁed by the left spectrum of
Figure 1B, where a ratio that should have been 10:1 has been
distorted to 5:1 by the presence of interfering reporter ions.
When the same yeast peptide precursor ion was interrogated
using a standard MS3 scan (Figure 1B, middle spectrum), due
to poor sensitivity we were unable to detect the lowest
abundance channels. In comparison, when we used the
MultiNotch MS3 method to coisolate and cofragment multiple
peaks from the MS2 spectrum, even the lowest abundance
Figure 4. (A) Eight colorectal cancer cell lines were grown in biological triplicate. Each replicate was digested with LysC, labeled with TMT,
fractionated, and analyzed using MultiNotch MS3 (3-h LC gradients). (B) All protein ratios from replicates 1 and 2 were plotted against each other.
In total this represents 172 704 quantitative ratios. (C) Across the three replicate we performed a one way ANOVA with Welch’s correction. (D) We
highlighted the protein expression proﬁle for two commonly studied proteins, EGFR and MSH6, and (E) the WT and mutant (G13D) forms of
KRAS.
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channels were detected and the ratios remained accurate
(Figure 1B, right spectrum).
In Figure 1C, we provide spectra of the MS3 precursor
populations used to generate the reporter ion distributions of
Figure 1B. The middle spectrum presents analysis of the
standard MS3 precursor population, while the bottom spectrum
presents the MultiNotch MS3 precursor population. For
reference we also include the spectrum on top, in which we
analyzed the MS2 fragment ion population prior to isolating the
MS3 precursor populations. By increasing the number of
precursor from 1 to 6, we are able to substantially increase the
ﬁnal reporter ion population. At the same time the notched
isolation waveforms preserve the speciﬁcity of the MS3 scan by
eﬀectively removing unwanted ions.
Analyzing the Entire Two-Proteome Data Set. In
Figure 3, we provide a more complete picture of the diﬀerence
in performance between the three methods. In separate 90 min
LC−MS analyses, we interrogated the two-proteome sample
using the MS2, standard MS3, and MultiNotch MS3 methods.
In Figure 3A, we show the distribution of TMT ions. As noted
earlier, the sensitivity of the standard MS3 method is quite
poor, and on average we only detected ∼200 TMT reporter
ions per MS3 spectrum. The MultiNotch MS3 scan typically
produced ∼2 500 reporter ions per MS3 spectrum. This is over
an order of magnitude more reporter ions per quantitative
spectrum, and it is also close to the number of reporter ions we
produced on average using the MS2 method (∼3 100).
Though, in the case of the MS3 measurements, we utilized
higher AGC targets and maximum injection times than for the
MS2 measurements (see Methods).
In Figure 3B we compare how accurately the three methods
measured the reporter ion ratios. We focused on the 10:1 and
4:1 ratios, where all the channels have interfering signals
(TMT-126/128 and TMT-127/128, respectively). We also
included a 1:1 ratio, which we derived from the two channels
with the lowest intensity (TMT-128/129). With this ratio one
of the channels is shared with an interfering human reporter ion
(TMT-128), while the other channel is pure (TMT-129). We
included this last ratio to highlight how interfering signals can
distort measured ratios upward as well and downward. In the
standard MS2 data, the 10:1 and 4:1 ratios distorted downward
such that the typical values across the entire LC−MS analysis
were 5:1 and 2:1, respectively. Even more distressing, the 1:1
ratio distorted upward such that typical values were 2:1.
Because of the coisolation and cofragmentation of interfering
ions during an MS2 analysis, we could no longer conﬁdently
measure the diﬀerence between ratios that should be 1:1 and
4:1. In contrast, with the MS3 methods we typically recorded
the expected ratios (i.e., 10:1, 4:1, and 1:1). For this analysis,
we required that all six reporter channels were present before
analyzing a given spectrum, which resulted in a more than 4-
fold increase of the number of quantiﬁed yeast spectra from the
MultiNotch MS3 method (1794), compared to the standard
MS3 method (438).
Analyzing an 8-Plex Sample of Colon Cancer Cell
Lines. Beyond demonstrating the technical capabilities of the
MultiNotch MS3 method with the two-proteome model, we
sought to demonstrate the practicality of the method using a
large-scale proteomics experiment. To this end, we prepared a
TMT 8-plex sample that consisted of eight diﬀerent colorectal
cancer cell lines: Colo-205, LoVo, DLD-1, SW48, HT-29,
HCT-15, HT-55, and HCT-116 (Figure 4A). We grew all eight
cell lines in biological triplicate, harvested the proteins, and
digested the resulting proteome samples with LysC. Following
digestion, we labeled the samples with the TMT reagents,
mixed the labeled peptides, and fractionated the mixtures using
oﬄine basic-pH reverse phase HPLC. We collected 24
fractions, which we then analyzed using a 3-h LC−MS3
method. To analyze each biological replicate required 3 days of
analysis time, and to collect the entire data set required 9 days.
Across the three biological replicates, the MultiNotch MS3
method quantiﬁed 8 378 proteins in at least one of the
replicates and 6 168 in all three. In the latter case, this
represents eight quantitative measurements per protein per
biological replicate. Considering that 8 TMT channels allow the
determination of 28 binary comparisons, the quantitative
breadth of these analyses entails 172 704 quantitative protein
abundance ratios measured in all three biological replicates.
Next, we compared the quantitative reproducibility between
replicate measurements. In Figure 4B, we show all the
quantitative ratios from the ﬁrst biological replicate plotted
against the ratios from the second. We observed high
correlation between the replicate measurements (Pearson
correlation coeﬃcient of 0.86), which conﬁrms the high
reproducibility of the MultiNotch MS3 method, as well as of
the TMT-based workﬂow, and of quantitative proteomics in
general. After all, the variation in this plot is the summation of
all the variances across the entire experiment, from cell culture
to mass spectrometer analysis.
Using data from the biological triplicate measurements, we
also performed a one way ANOVA with Welch’s correction for
unequal variance. We adjusted the resulting p-values using the
Benjamini−Hochberg multiple test correction (Figure 4C).
Across the biological data set, we detected 4 107 proteins where
the cell-line speciﬁc expression proﬁle varied in a statistically
signiﬁcant manner (adjusted p-value <0.01). These data
demonstrate strikingly diﬀerent expression levels for thousands
of proteins. Nearly 10% of the quantiﬁed proteins showed a 10-
fold diﬀerence somewhere in their expression proﬁles, and
∼75% demonstrated at least one 2-fold diﬀerence.
As examples, we highlight two proteins known to often play
central roles in colorectal tumorigenesis: EGFR and MSH6
(Figure 4D). EGFR was quantiﬁed based on an average of 26
peptides per biological replicate. MSH6 was quantiﬁed based
on an average of 14 peptides/replicate. Indeed, the average
number of peptides used for quantitation in each replicate was
∼88 000. This good protein coverage, and the high accuracy of
the MultiNotch MS3 method, translates into high reproduci-
bility between replicates.
In Figure 4E, we highlight the expression proﬁle of KRAS, a
protein tightly associated with many cancers. As with EGFR
and MSH6, we observed good protein coverage (>10 peptides
per replicate) and high reproducibility between the biological
replicates. In the bottom panel of Figure 4E, we highlight the
detection and quantitation of a peptide from a mutated form of
KRAS. Four of the cell lines examined are known to harbor this
KRAS-activating mutation (DLD-1, HCT-116, HCT-15, and
Lovo). This mutation involves a substitution of an aspartic acid
(D) for the glycine (G) at the 13th position. Because this
mutation entails a single amino acid substitution, to
unambiguously quantify the mutated form of the protein, the
MS3 method must successfully interrogate a single peptide in
the pool of hundreds of thousands that comprise the sample. In
spite of this hurdle, the MultiNotch MS3 quantiﬁed the
mutated form in all three biological replicates.
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Quantitative Proteomics Reveals Cellular Pathways
Deregulated in the Cancer Cell Lines. A recent review by
Vogelstein and colleagues detailed a set of genes frequently
mutated across many cancers and are thus likely to be drivers of
the disease.34,35 The MultiNotch MS3 method detected many
diﬀerentially expressed proteins in this gene set across several
biological processes (Figure 5A). These included chromatin
modiﬁcation, PI3K and RAS signaling, and the cell cycle.
Mapping these proteins onto the ReactomeFI network (Figure
5B)33 revealed four modules that correlate with known
colorectal cancer biology. Notably, DNA mismatch repair
defects are a primary driver of mutational burden in heritable
colorectal cancers.36 Similarly, signaling downstream of EGFR
and WNT are often a critical drivers in many colorectal
cancers.37
Principal component analysis on all quantiﬁed proteins in the
entire MultiNotch MS3 data set (Figure 5C)38 revealed that
PC1 clearly separated hypermutated from nonhypermutated
cell lines. This division is prognostic for colorectal cancers, as
patients with hypermutated tumors fare better.36 Several of the
primary contributors to PC1 are also mutated at a high rate in
colorectal cancers (e.g., MSH6 and P53, Figure 5D).
The MultiNotch MS3 data reproduced a recent report that
SMAD4 is highly expressed in hypermutated tumors (Figure
5D), correlating with a positive prognosis.39 That work did not
quantify the diﬀerence between the two phenotypes, and here
we report an average 5.5-fold up-regulation of SMAD4 protein
in the hypermutated cell lines.
Using the SMAD4 expression proﬁle as a prototype, we
looked for other proteins encoded by the Vogelstein gene set
that showed similar expression patterns (Figure 5E). The top
hits for nearby proﬁles were not for the BMP/TGF-Beta
signaling pathways but rather for telomere maintenance
(WRN), Notch (NOTCH2), and MAPK signaling (RAF1).
WRN and NOTCH2 have been previously linked to colorectal
cancer.40,41 In contrast to BRAF, RAF1 (CRAF) has not been
linked to colorectal cancer, but these results suggest that it
might play a role in hypermutated tumors.
Mutations in IDH1 and IDH2 are frequently found in a
number of cancer types.34,42 Surprisingly, higher IDH2
expression was one of the best predictors of the non-
hypermutated phenotype in our cell lines (Figure 5D) despite
not being traditionally associated with colorectal cancer. As
with SMAD4, we used IDH2 as a prototype to look for similar
expression proﬁles (Figure 5F). Other metabolic proteins,
however, were not the closest proﬁles to IDH2. Rather, excision
repair (ERCC5), PPAR gamma signaling (PPARG), and EGFR
signaling (ERBB2) were closer matches. Both PPARG and
Figure 5. (A) Number of members of the core pathways annotated by Vogelstein et al. showing signiﬁcantly diﬀerent expression. (B) The lists of
proteins with altered expression were mapped on to the Reactome Pathway Database and clustered into graph modules. (C) Principal component
analysis of the quantiﬁed proteome shows that PC1 distinguishes hypermutated from nonhypermutated cell lines. (D) The top contributors to PC1
among the Vogelstein gene set. SMAD4 and IDH2 are preferentially expressed in the hypermutated and nonhypermutated lines, respectively. (E,F)
The Vogelstein gene set proteins with expression proﬁles most similar to SMAD4 (E) and IDH2 (F).
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ERBB2 have been well tied to colorectal cancer.36,43 In contrast,
ERCC5 has not been associated with colorectal cancer. The up-
regulation suggests a possible role for DNA excision repair in
nonhypermutated tumors
■ DISCUSSION
The combination of quantitative isobaric reagents and the
MultiNotch MS3 method facilitated the quantitation of 8 378
proteins across biological triplicates. Taking into account that
every quantiﬁed protein contains expression information for
eight diﬀerent cells lines, and limiting our scope to only
measurements that were made in all three biological replicates,
we reproducibly quantiﬁed 172 704 protein abundance changes
between individual cell lines. To achieve similar breadth of
quantitative analysis, including eight samples and three
biological replicates, would require 24 separate experiments
using a simple duplex quantitative method (e.g., SILAC). In
contrast we only need three separate experiments using the
TMT 8-plex workﬂow.
Though isobaric reagents for relative quantitation (e.g., TMT
and iTRAQ) always had the potential to increase sample
throughput, the actual utility of the tags was questionable due
to ratio distortion caused by interfering ions. Though the
standard MS3 method successfully countered the detrimental
eﬀects of the interfering ions, this method entailed a substantial
sensitivity penalty. Herein, we overcome this limitation by
coisolating multiple MS2 fragment ions using isolation
waveforms with multiple notches (i.e., SPS), thereby converting
far more MS1 precursor ions into MS3 TMT reporter ions.
It is remarkable how much of the MS2 signal can be captured
in the MS3 precursor population using a MultiNotch MS3 scan.
Typically 10 MS2 fragment ions were targeted for synchronous
precursor selection, which translated into ∼40% of the MS2
total ion current (Figure 2). Taking into account the
fragmentation eﬃciency of CID, we retained ∼25% of our
initial MS1 precursor population in the MS3 precursor
population. This is a vast improvement over the traditional
MS3 approach, where ∼5% of the initial precursor population
was retained in the MS3 precursor population. Coupled
together with some additional algorithms for selecting
precursors, setting collision energies, and intelligently scaling
ion injection times, we see a 10-fold increase in TMT reporter
ion intensities with the MultiNotch MS3 approach, relative to
the standard MS3 scan type (Figure 3).
On the basis of the success of this work, Thermo Scientiﬁc
has implemented a MultiNotch MS3 method. This method also
captures multiple MS2 fragment ions in the MS3 precursor
population using isolation waveforms with multiple frequency
notches (i.e., synchronous precursor selection). They have
implemented this method on the Orbitrap Fusion mass
spectrometer. Preliminary data collected using the Orbitrap
Fusion matches with the trends presented in this manuscript,
i.e., that MS2-based measurements of TMT ratios are
inaccurate due to the coisolation and cofragmentation of
interfering ions and that the MultiNotch MS3 method
eﬀectively counters these interfering signals (Figure S7 in the
Supporting Information). We also observed that improvements
in parallel ion processing and active ion management
dramatically reduce the scan overhead associated with MS3
analysis. We are currently preparing a manuscript that further
details the performance characteristics of this instrument.
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